Heading 4
Heading 4
Heading 4
Heading 4
Heading 4
Heading 4
Heading 4
Heading 4
Heading 4
Heading 4
Heading 4
Heading 4
Pegheal 6 mg Injection
Manufacturer/Marketed By : Cadila Healthcare Ltd
$38.76 $30.24
Sidmex Inovia offers bulk export supply of Pegheal 6 mg Injection (Pegfilgrastim 6 mg) for hospitals, distributors and tender buyers. Request a quote with your quantity and destination country.Documents, cold-chain...
Pegfilgrastim 6 mg
Active Pharmaceutical Ingredient
Pegheal 6 mg Injection
$38.76
$30.24
Sidmex Inovia offers bulk export supply of Pegheal 6 mg Injection (Pegfilgrastim 6 mg) for hospitals, distributors and tender buyers. Request a quote with your quantity and destination country.
Documents, cold-chain shipping and tenders: see our Export FAQ.
Priority markets: United Arab Emirates, Brazil, Turkey, Singapore, Kenya, Somalia, Ghana, Saudi Arabia, Mauritius, Nigeria, Tanzania, Senegal, Democratic Republic of the Congo, Mali. We also export worldwide, including:
Middle East: Oman, Qatar, Kuwait, Bahrain, Iraq, Jordan, Lebanon, Yemen, Iran
Africa: Egypt, Algeria, Morocco, Libya, Burkina Faso, Côte d'Ivoire, Gambia, Rwanda, Ethiopia, Djibouti, South Africa, Zimbabwe
Asia: Sri Lanka, Bangladesh, Nepal, Maldives, Philippines, Vietnam, Laos, Malaysia, Thailand, Taiwan
CIS & Eastern Europe: Russia, Kazakhstan, Uzbekistan, Azerbaijan, Georgia, Serbia, Latvia, Tajikistan
Latin America & Caribbean: Mexico, Chile, Peru, Colombia, Bolivia, Venezuela
Europe & Other: Switzerland, United Kingdom, Canada
Related products we supply: Alburel 20 gm/100 ml Injection
Pegheal 6 mg Injection is an essential prescription medication designed to prevent infections in patients undergoing cancer treatment. This powerful injectable solution aids the body in increasing the production of white blood cells, which play a crucial role in defending against potential infections. In addition to its primary use, Pegheal can also be beneficial for individuals exposed to significant radiation levels, as it supports their recovery process by bolstering the immune response. It is important to be aware of potential side effects, including allergic reactions and bone pain, and to discuss any pre-existing health conditions with your healthcare provider prior to use. Pegheal is typically administered under medical supervision, ensuring that patients receive the appropriate care and monitoring during their treatment. As with any medication, adherence to prescribed dosages and consultation with a healthcare professional is essential for optimal results. This injection not only plays a vital role in enhancing immunity but also contributes to the overall well-being of patients navigating the challenges of cancer therapy.
Active Pharmaceutical Ingredient
Uses
• Pegheal 6 mg injection is primarily used to prevent infections in patients undergoing chemotherapy. Chemotherapy can significantly weaken the immune system, making individuals more susceptible to infections. By administering Pegheal 6 mg injection, healthcare providers aim to bolster the body’s defense mechanisms during this vulnerable period. This proactive approach helps reduce the risk of complications associated with infections.
• In addition to infection prevention, Pegheal 6 mg injection plays a critical role in supporting patients with neutropenia caused by chemotherapy. Neutropenia is a condition characterized by low levels of neutrophils, a type of white blood cell essential for fighting infections. The use of Pegheal 6 mg injection can help stimulate the production of these white blood cells, enhancing the patient’s ability to combat potential infections. This is particularly beneficial during the recovery phase of chemotherapy.
• Pegheal 6 mg injection is also utilized in patients with certain hematological disorders that require chemotherapy. These patients may experience compromised immune function, making them more prone to infections. By administering Pegheal 6 mg injection, healthcare providers can help mitigate these risks. The injection serves as a valuable tool in managing the overall health and safety of patients undergoing intensive treatments.
• Lastly, Pegheal 6 mg injection is commonly recommended for individuals undergoing stem cell transplantation. This procedure often leads to a significant decline in immune function, increasing the risk of infections. Pegheal 6 mg injection aids in the recovery of the immune system post-transplant, allowing for a more robust response to any potential infections. Its use is an integral part of the care plan for patients in this critical phase of treatment.
Benefits
Pegheal 6 mg works by stimulating your body's immune system to increase the production of white blood cells. The cells that help us fight infections are called white blood cells. You must use this medicine under medical supervision to make it really effective. To help prevent infections, avoid being in crowded places and wash your hands often. Drink plenty of fluids, unless you are told otherwise by your doctor or health care professional.
Side Effects
Pegheal 6 mg Injection adverse effects can vary depending on various factors. Some of the common and severe adverse effects are listed below.
Most Common Side Effects
• Dizziness
• Headache
• Appetite Loss
• Constipation
• Infection in the Urinary and Respiratory Tract
• Hair Loss
• Low Count of Red Blood cells
• Fluctuation in the Blood Pressure
• Diarrhoea
• Dizziness
• Nose Bleeds
• Tingling in Feet and hands
• Chest Pain
• Pain during Urination
Common Side Effects
• Rashes
• Headache
• Nausea
• Bone pain
• Leg pain
How To Use
Pegheal Injection is given through intravenous infusion by your doctor or nurse. Follow the guidelines of the doctor carefully during the treatment. Please do not self-administer this Pegheal 6 mg.
Safety Advice
• Alcohol: It is not known whether it is safe to drink alcohol with Pegheal Injection. Consult your medical doctor for advice.
• Kidney: Pegheal 6 mg Injection is safe to use in patients with kidney disease. No dose change is recommended in patients with kidney impairment, including those with end-stage kidney disease.
• Breastfeeding: Pegheal 6 mg Injection should not be given to lactating women. There is no clinical experience with nursing women.
• Liver: There is only a limited amount of information available on the use of Pegheal 6 mg Injection in patients with liver disease. Consult your medical doctor for advice.
• Pregnancy: Pegheal 6 mg Injection is not recommended during pregnancy or in women who may become pregnant and are not using contraceptives. There are no data available on the use of Pegheal 6 mg Injection in pregnant women. Studies in animals have shown toxicity to the reproductive system. The potential risk to the human embryo or fetus is not known.
• Driving: Pegheal 6 mg has no or negligible effects on the ability to drive or to use machines.
Disclaimer
Sidmex Inovia strives to provide accurate and reliable information; however, all content on this website, including product descriptions and compositions, is for informational purposes only and should not be considered a substitute for professional medical advice, diagnosis, or treatment.
Users are advised to consult a qualified healthcare professional before making any medical decisions. The information provided should not be used for self-diagnosis or self-medication.
All products listed are intended strictly for B2B and bulk inquiry purposes only. Sidmex Inovia does not promote direct consumer use and aims to support, not replace, the healthcare professional–patient relationship.
Product names, trademarks, and brands belong to their respective owners, and their use does not imply any affiliation or endorsement. Sidmex Inovia shall not be held responsible for any consequences arising from the use of the information provided on this website.